Form 8-K

0001171843-22-007170.txt : 20221107 0001171843-22-007170.hdr.sgml : 20221107 20221107160537 ACCESSION NUMBER: 0001171843-22-007170 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20221107 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221107 DATE AS OF CHANGE: 20221107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shockwave Medical, Inc. CENTRAL INDEX KEY: 0001642545 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 270494101 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38829 FILM NUMBER: 221365395 BUSINESS ADDRESS: STREET 1: 5403 BETSY ROSS DRIVE CITY: SANTA CLARA STATE: CA ZIP: 95054 BUSINESS PHONE: (510) 279-4262 MAIL ADDRESS: STREET 1: 5403 BETSY ROSS DRIVE CITY: SANTA CLARA STATE: CA ZIP: 95054 FORMER COMPANY: FORMER CONFORMED NAME: ShockWave Medical, Inc. DATE OF NAME CHANGE: 20150515 8-K 1 f8k_110722.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 7, 2022

_______________________________

Shockwave Medical, Inc.

(Exact name of registrant as specified in its charter)

_______________________________

Delaware	001-38829	27-0494101
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

5403 Betsy Ross Drive

Santa Clara, California 95054

(Address of Principal Executive Offices) (Zip Code)

(510) 279-4262

(Registrant's telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, par value $0.001 per share	SWAV	Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On November 07, 2022, the Company issued a press release (the “Press Release”) announcing its financial results for the three months ended September 30, 2022. A copy of the Press Release is attached as Exhibit 99.1 to this current report on Form 8-K.

The information under Item 2.02 in this current report on Form 8-K and the related information in the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number		Description

99.1		Press Release dated November 7, 2022
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Shockwave Medical, Inc.


Date: November 7, 2022	By:	/s/ Daniel K. Puckett
		Daniel K. Puckett
		Chief Financial Officer

EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling

EXHIBIT 99.1

Shockwave Medical Reports Third Quarter 2022 Financial Results

SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended September 30, 2022.

Recent Highlights

Recognized revenue of $131.3 million for the third quarter of 2022, representing an increase of 102% from the same period in 2021
Received FDA Clearance for the Shockwave IVL System with the Shockwave L⁶ Peripheral IVL Catheter
Received CE marking for the Shockwave C²⁺ coronary catheter in Europe
Granted reimbursement for the Shockwave C² Coronary IVL Catheter by the Japanese Ministry of Health, Labour and Welfare (MHLW) in Japan

“Our third quarter achievements were encouraging across the entire Shockwave organization. Sales of all products, both in the U.S. and international markets, outperformed expectations, and operationally our accomplishments continue to be the backbone of our success,” said Doug Godshall, President and Chief Executive Officer of Shockwave Medical. “These results were particularly impressive in light of the many ongoing macro issues we have all seen across the globe. Despite these challenges, our team and our customers have been able to adapt and remain focused on using our IVL technology to treat patients suffering from calcified vascular disease.”

Third Quarter 2022 Financial Results

Revenue for the third quarter ended September 30, 2022, was $131.3 million, a 102% increase from $65.2 million in the same period of 2021. The growth was primarily driven by the launch of the coronary product, Shockwave C², in the U.S. in February 2021, continued recovery from the pandemic impact and increased adoption of Shockwave products.

Gross profit for the third quarter of 2022 was $113.5 million compared to $54.2 million for the third quarter of 2021. Gross margin for the third quarter of 2022 was 86%, as compared to 83% in the third quarter of 2021. The increase in gross margin was primarily driven by product mix along with continued improvement in manufacturing productivity and process efficiencies.

Total operating expenses for the third quarter of 2022 were $76.7 million, a 49% increase from $51.4 million in the third quarter of 2021. The increase was primarily driven by sales force expansion in the U.S. and higher headcount to support the growth of the business.

Net income for the third quarter of 2022 was $35.0 million, compared to net income of $1.9 million in the same period of 2021. Basic and diluted net income per share for the third quarter of 2022 was $0.97 and $0.92, respectively.

Cash, cash equivalents and short-term investments totaled $250.7 million as of September 30, 2022.

2022 Financial Guidance

Shockwave Medical projects revenue for the full year 2022 to range from $483 million to $488 million, which represents 104% to 106% growth over the Company’s prior year revenue. This compares to previous revenue guidance of $465 million to $475 million.

Conference Call

Shockwave Medical will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on Monday, November 7, 2022, to discuss its third quarter 2022 financial results. The call may be accessed by dialing 877-704-4453 for domestic callers or 201-389-0920 for international callers, using conference ID:13733213. A live and archived webcast of the event will be available at https://ir.shockwavemedical.com/.

About Shockwave Medical, Inc.

Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave Medical aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which Shockwave Medical refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit www.shockwavemedical.com.

Forward-Looking Statements

This press release contains statements relating to our expectations, projections, beliefs, and prospects, which are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” and similar expressions, and the negative of these terms. You are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements are only predictions based on our current expectations, estimates, and assumptions, valid only as of the date they are made, and subject to risks and uncertainties, some of which we are not currently aware.

Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others: the impact of the COVID-19 pandemic on our operations, financial results, and liquidity and capital resources, including the impact on our sales, expenses, supply chain, manufacturing, research and development activities, clinical trials, and employees; our ability to develop, manufacture, obtain and maintain regulatory approvals for, market and sell, our products; our expected future growth, including the size and growth potential of the markets for our products; our ability to obtain coverage and reimbursement for procedures performed using our products; our ability to scale our organizational culture; the impact of the development, regulatory approval, efficacy and commercialization of competing products; the loss of key scientific or management personnel; our ability to develop and maintain our corporate infrastructure, including our internal controls; our financial performance and capital requirements; and our ability to obtain and maintain intellectual property protection for our products, as well as our ability to operate our business without infringing the intellectual property rights of others. These factors, as well as others, are discussed in our filings with the Securities and Exchange Commission (SEC), including in Part I, Item IA - Risk Factors in our most recent Annual Report on Form 10-K filed with the SEC, and in our other periodic and other reports filed with the SEC. Except to the extent required by law, we do not undertake to update any of these forward-looking statements after the date hereof to conform these statements to actual results or revised expectations.

Media Contact:
Scott Shadiow
+1.317.432.9210
sshadiow@shockwavemedical.com

Investor Contact:
Debbie Kaster
dkaster@shockwavemedical.com



SHOCKWAVE MEDICAL, INC.
Balance Sheet Data
(in thousands)

	September 30, 2022			December 31, 2021
	(Unaudited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	127,779		$	89,209
Short-term investments		122,888			111,772
Accounts receivable, net		64,224			37,435
Inventory		68,974			42,978
Prepaid expenses and other current assets		11,393			4,508
Total current assets		395,258			285,902
Operating lease right-of-use assets		33,107			27,496
Property and equipment, net		39,265			24,361
Equity method investment		4,573			5,987
Other assets		3,606			1,936
TOTAL ASSETS	$	475,809		$	345,682
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable	$	3,469		$	3,520
Term notes, current portion		—			5,500
Accrued liabilities		49,492			40,870
Lease liability, current portion		1,260			1,738
Total current liabilities		54,221			51,628
Lease liability, noncurrent		38,532			28,321
Term notes, noncurrent portion		14,853			11,630
Related party contract liability, noncurrent portion		12,273			12,273
TOTAL LIABILITIES		119,879			103,852
STOCKHOLDERS’ EQUITY:
Preferred stock		—			—
Common stock		36			35
Additional paid-in capital		535,230			494,806
Accumulated other comprehensive loss		(1,612	)		(202	)
Accumulated deficit		(177,724	)		(252,809	)
TOTAL STOCKHOLDERS’ EQUITY		355,930			241,830
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	475,809		$	345,682


SHOCKWAVE MEDICAL, INC.
Statement of Operations Data
(Unaudited)
(in thousands, except share and per share data)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
		2022			2021			2022			2021
Revenue:
Product revenue	$	131,330		$	65,155		$	345,707		$	152,963
Cost of revenue:
Cost of product revenue		17,874			10,949			47,494			28,775
Gross profit		113,456			54,206			298,213			124,188
Operating expenses:
Research and development		20,177			13,735			57,956			35,827
Sales and marketing		42,082			28,393			118,558			78,098
General and administrative		14,434			9,265			39,988			25,117
Total operating expenses		76,693			51,393			216,502			139,042
Income (loss) from operations		36,763			2,813			81,711			(14,854	)
Income (loss) from equity method investment		97			(342	)		(1,414	)		(5,865	)
Interest expense		(316	)		(165	)		(917	)		(795	)
Other expense, net		(1,423	)		(280	)		(3,206	)		(369	)
Net income (loss) before taxes		35,121			2,026			76,174			(21,883	)
Income tax provision		118			78			1,089			195
Net income (loss)	$	35,003		$	1,948		$	75,085		$	(22,078	)
Net income (loss) per share, basic	$	0.97		$	0.06		$	2.10		$	(0.63	)
Net income (loss) per share, diluted	$	0.92		$	0.05		$	1.99		$	(0.63	)
Shares used in computing net income (loss) per share, basic		36,003,931			35,207,276			35,807,264			35,013,072
Shares used in computing net income (loss) per share, diluted		37,948,049			37,567,176			37,813,107			35,013,072

EX-101.SCH 3 gnw-20190101.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 gnw-20190101_def.xml XBRL DEFINITION FILE EX-101.LAB 5 gnw-20190101_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 gnw-20190101_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover	Nov. 07, 2022
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Nov. 07, 2022
Entity File Number	001-38829
Entity Registrant Name	Shockwave Medical, Inc.
Entity Central Index Key	0001642545
Entity Tax Identification Number	27-0494101
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	5403 Betsy Ross Drive
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054
City Area Code	510
Local Phone Number	279-4262
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common stock, par value $0.001 per share
Trading Symbol	SWAV
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

XML 8 f8k_110722_htm.xml IDEA: XBRL DOCUMENT 0001642545 2022-11-07 2022-11-07 iso4217:USD shares iso4217:USD shares 0001642545 false 8-K 2022-11-07 Shockwave Medical, Inc. DE 001-38829 27-0494101 5403 Betsy Ross Drive Santa Clara CA 95054 510 279-4262 false false false false Common stock, par value $0.001 per share SWAV NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://globenewswire.com/role/Cover Cover Cover 1 false false All Reports Book All Reports f8k_110722.htm exh_991.htm gnw-20190101.xsd gnw-20190101_def.xml gnw-20190101_lab.xml gnw-20190101_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f8k_110722.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "local": [ "gnw-20190101_def.xml" ] }, "inline": { "local": [ "f8k_110722.htm" ] }, "labelLink": { "local": [ "gnw-20190101_lab.xml" ] }, "presentationLink": { "local": [ "gnw-20190101_pre.xml" ] }, "schema": { "local": [ "gnw-20190101.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "gnw", "nsuri": "http://globenewswire.com/20190101", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "f8k_110722.htm", "contextRef": "Form8K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://globenewswire.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "f8k_110722.htm", "contextRef": "Form8K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 15 0001171843-22-007170-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-22-007170-xbrl.zip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